MedTrace Logo

Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand

NCT00197639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2010-11-15

No results posted yet for this study

Summary

This study looks at the ways indinavir drug levels, when boosted with ritonavir, may vary from patient to patient. The study population are HIV+ Thai individuals.

Conditions

  • HIV Infection

Interventions

DRUG

Ritonavir-boosted indinavir

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Marc Lallemant · Harvard School of Public Health (HSPH)

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2009-05-31
Completion
2010-08-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00197639 on ClinicalTrials.gov